401 related articles for article (PubMed ID: 28487469)
1. Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction.
Prakoso D; De Blasio MJ; Qin C; Rosli S; Kiriazis H; Qian H; Du XJ; Weeks KL; Gregorevic P; McMullen JR; Ritchie RH
Clin Sci (Lond); 2017 Jun; 131(12):1345-1360. PubMed ID: 28487469
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes.
Prakoso D; De Blasio MJ; Tate M; Kiriazis H; Donner DG; Qian H; Nash D; Deo M; Weeks KL; Parry LJ; Gregorevic P; McMullen JR; Ritchie RH
Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H840-H852. PubMed ID: 32142359
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling.
De Blasio MJ; Huynh K; Qin C; Rosli S; Kiriazis H; Ayer A; Cemerlang N; Stocker R; Du XJ; McMullen JR; Ritchie RH
Free Radic Biol Med; 2015 Oct; 87():137-47. PubMed ID: 25937176
[TBL] [Abstract][Full Text] [Related]
4. Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart.
Prakoso D; Lim SY; Erickson JR; Wallace RS; Lees JG; Tate M; Kiriazis H; Donner DG; Henstridge DC; Davey JR; Qian H; Deo M; Parry LJ; Davidoff AJ; Gregorevic P; Chatham JC; De Blasio MJ; Ritchie RH
Cardiovasc Res; 2022 Jan; 118(1):212-225. PubMed ID: 33576380
[TBL] [Abstract][Full Text] [Related]
5. Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes.
Ritchie RH; Love JE; Huynh K; Bernardo BC; Henstridge DC; Kiriazis H; Tham YK; Sapra G; Qin C; Cemerlang N; Boey EJ; Jandeleit-Dahm K; Du XJ; McMullen JR
Diabetologia; 2012 Dec; 55(12):3369-81. PubMed ID: 23001375
[TBL] [Abstract][Full Text] [Related]
6. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.
Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH
Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497
[TBL] [Abstract][Full Text] [Related]
7. Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction.
Weeks KL; Gao X; Du XJ; Boey EJ; Matsumoto A; Bernardo BC; Kiriazis H; Cemerlang N; Tan JW; Tham YK; Franke TF; Qian H; Bogoyevitch MA; Woodcock EA; Febbraio MA; Gregorevic P; McMullen JR
Circ Heart Fail; 2012 Jul; 5(4):523-34. PubMed ID: 22705768
[TBL] [Abstract][Full Text] [Related]
8. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin.
Dai B; Li H; Fan J; Zhao Y; Yin Z; Nie X; Wang DW; Chen C
Cardiovasc Diabetol; 2018 Sep; 17(1):123. PubMed ID: 30180843
[TBL] [Abstract][Full Text] [Related]
9. Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension.
Waddingham MT; Edgley AJ; Astolfo A; Inagaki T; Fujii Y; Du CK; Zhan DY; Tsuchimochi H; Yagi N; Kelly DJ; Shirai M; Pearson JT
Cardiovasc Diabetol; 2015 Jul; 14():92. PubMed ID: 26194354
[TBL] [Abstract][Full Text] [Related]
10. Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus.
Gimenes R; Gimenes C; Rosa CM; Xavier NP; Campos DHS; Fernandes AAH; Cezar MDM; Guirado GN; Pagan LU; Chaer ID; Fernandes DC; Laurindo FR; Cicogna AC; Okoshi MP; Okoshi K
Cardiovasc Diabetol; 2018 Jan; 17(1):15. PubMed ID: 29343259
[TBL] [Abstract][Full Text] [Related]
11. Allopurinol attenuates left ventricular dysfunction in rats with early stages of streptozotocin-induced diabetes.
Gao X; Xu Y; Xu B; Liu Y; Cai J; Liu HM; Lei S; Zhong YQ; Irwin MG; Xia Z
Diabetes Metab Res Rev; 2012 Jul; 28(5):409-17. PubMed ID: 22389139
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy.
Dong B; Yu QT; Dai HY; Gao YY; Zhou ZL; Zhang L; Jiang H; Gao F; Li SY; Zhang YH; Bian HJ; Liu CX; Wang N; Xu H; Pan CM; Song HD; Zhang C; Zhang Y
J Am Coll Cardiol; 2012 Feb; 59(8):739-47. PubMed ID: 22340266
[TBL] [Abstract][Full Text] [Related]
13. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.
Huynh K; Bernardo BC; McMullen JR; Ritchie RH
Pharmacol Ther; 2014 Jun; 142(3):375-415. PubMed ID: 24462787
[TBL] [Abstract][Full Text] [Related]
14. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
[TBL] [Abstract][Full Text] [Related]
15. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice.
Huynh K; Kiriazis H; Du XJ; Love JE; Gray SP; Jandeleit-Dahm KA; McMullen JR; Ritchie RH
Free Radic Biol Med; 2013 Jul; 60():307-17. PubMed ID: 23454064
[TBL] [Abstract][Full Text] [Related]
16. Monoamine oxidase-A is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy.
Umbarkar P; Singh S; Arkat S; Bodhankar SL; Lohidasan S; Sitasawad SL
Free Radic Biol Med; 2015 Oct; 87():263-73. PubMed ID: 26122707
[TBL] [Abstract][Full Text] [Related]
17. Fenofibrate increases cardiac autophagy via FGF21/SIRT1 and prevents fibrosis and inflammation in the hearts of Type 1 diabetic mice.
Zhang J; Cheng Y; Gu J; Wang S; Zhou S; Wang Y; Tan Y; Feng W; Fu Y; Mellen N; Cheng R; Ma J; Zhang C; Li Z; Cai L
Clin Sci (Lond); 2016 Apr; 130(8):625-41. PubMed ID: 26795437
[TBL] [Abstract][Full Text] [Related]
18. Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits.
Zhang X; Zhang Z; Yang Y; Suo Y; Liu R; Qiu J; Zhao Y; Jiang N; Liu C; Tse G; Li G; Liu T
Cardiovasc Diabetol; 2018 Dec; 17(1):160. PubMed ID: 30591063
[TBL] [Abstract][Full Text] [Related]
19. Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat.
Tate M; Deo M; Cao AH; Hood SG; Huynh K; Kiriazis H; Du XJ; Julius TL; Figtree GA; Dusting GJ; Kaye DM; Ritchie RH
Diab Vasc Dis Res; 2017 Sep; 14(5):423-433. PubMed ID: 28565941
[TBL] [Abstract][Full Text] [Related]
20. Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis.
Sun X; Chen RC; Yang ZH; Sun GB; Wang M; Ma XJ; Yang LJ; Sun XB
Food Chem Toxicol; 2014 Jan; 63():221-32. PubMed ID: 24269735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]